Evergreen Theragnostics Email Format
Pharmaceutical ManufacturingNew Jersey, United States51-200 Employees
Evergreen Theragnostics is a United States-based radiopharmaceutical contract development and manufacturing organization founded in 2019. The company focuses on the commercialization of theranostic radiopharmaceuticals, as well as manufacturing process development and regulatory affairs management for partner programs. Headquartered in Springfield, New Jersey, it operates as a mid-sized firm with a focused expertise in this specialized field. Its customers include biopharma and research organizations seeking development, manufacturing, and regulatory support for radiopharmaceutical products. Positioned within the pharmaceutical manufacturing industry, Evergreen Theragnostics provides end-to-end CDMO services tailored to theranostic programs. In 2025, Evergreen Theragnostics was acquired by Lantheus, a leading radiopharmaceutical-focused company, reflecting a consolidation within the sector.